Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
Authors
- Maike Stegemann
- Sigrid Macherndl-Spandl
- Mario Mairhofer
- Sabine Kaltenbrunner
- Veronika Buxhofer-Ausch
- Johannes Clausen
- Andreas Petzer
- Clemens A. Schmitt
Journal
- Leukemia & Lymphoma
Citation
- Leuk Lymphoma 67 (5): 1147-1151